RGNX

REGENXBIO INC

RGNX·75901B107·US·Common Stock·Healthcare - Biotechnology-13D/G

RGNX (REGENXBIO INC) is held by 104 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($48.5M), JPMORGAN CHASE & CO ($27.1M), STATE STREET CORP ($22.9M). Net institutional sentiment: Mixed.

104
Holders
(10 Elite)
$271.8M
Total Value
54% (105)
Consensus
57 buying - 48 selling
13F: Insider & Congress:
RGNX

Smart Money Verdict

View all
Held by 104 funds
10 elite

Who's Trading

ActivistJPMORGAN CHASE & COJPMORGAN CHASE & CO4.4%Jun 4, 2026
ActivistSTATE STREET CORPORATIONSTATE STREET CORPORATION5.3%May 12, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderPSPAKOLA STEVESell $53KMar 10, 2026
ActivistBPBlackRock Portfolio Management LLC4.1%Jan 21, 2026
InsiderSCSimpson CurranSell $263KOct 9, 2025
InsiderSCSimpson CurranSell $76KSep 29, 2025
InsiderSCSimpson CurranSell $77KSep 10, 2025
ActivistRERedmile Group, LLC9.9%Aug 14, 2025
ActivistBlackRock, Inc.BlackRock, Inc.7.3%Apr 24, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
5.8M(+0.5%)$48.5M0.0%+43.71%
29
Decreased
3.5M(-2.0%)$27.1M0.0%+45.26%
0
Increased
2.7M(+19.4%)$22.9M0.0%-17.96%
34
Increased
2.1M(+2.5%)$17.3M0.0%+1.36%
29
New
2M$16.8M0.0%+23.36%
39
Increased
1.8M(+3.0%)$15.4M0.0%+34.12%
29
Increased
1.3M(+196.0%)$11M0.0%+11.56%
45
Decreased
1.1M(-0.7%)$9.5M0.0%-64.81%
0
Decreased
1.1M(-22.8%)$8.8M0.0%+20.58%
0
New
1M$8.5M0.0%+23.36%
38
Increased
1M(+11.8%)$8.5M0.0%-35.71%
31
Decreased
980,611(-15.5%)$8.2M0.0%-29.76%
0
Decreased
582,016(-11.6%)$4.9M0.0%+12.88%
0
Increased
554,892(+327.0%)$4.6M0.0%+20.33%
43
Increased
393,640(+5.3%)$3.3M0.0%-73.06%
28
Increased
392,769(+17.2%)$3.3M0.0%-12.29%
31
Decreased
390,601(-0.2%)$3.3M0.0%-63.37%
0
Increased
324,860(+8.1%)$2.7M0.0%+40.04%
28
New
312,064$2.6M0.0%+23.36%
36
Increased
311,268(+17.0%)$2.6M0.0%+12.40%
30

Showing 1-20 of 114

1 / 6
RGNXRGNXREGENXBIO INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used